These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3510654)

  • 1. Cutaneous immunological studies in diagnosis of acute graft-versus-host disease.
    Dreno B; Milpied N; Harousseau JL; Stalder JF; Bureau B; Milpied B; Barriere H
    Br J Dermatol; 1986 Jan; 114(1):7-15. PubMed ID: 3510654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
    Breathnach SM; Shimada S; Kovac Z; Katz SI
    J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial class II antigen expression in cutaneous graft-versus-host disease.
    Beschorner WE; Farmer ER; Saral R; Stirling WL; Santos GW
    Transplantation; 1987 Aug; 44(2):237-43. PubMed ID: 3307048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological analysis of the skin in graft versus host disease.
    Lampert IA; Janossy G; Suitters AJ; Bofill M; Palmer S; Gordon-Smith E; Prentice HG; Thomas JA
    Clin Exp Immunol; 1982 Oct; 50(1):123-31. PubMed ID: 6756725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation.
    Volc-Platzer B; Rappersberger K; Mosberger I; Hinterberger W; Emminger-Schmidmeier W; Radaszkiewicz T; Wolff K
    J Invest Dermatol; 1988 Aug; 91(2):162-8. PubMed ID: 3294303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of cutaneous graft-versus-host disease after allogeneic bone marrow transplantation.
    Girolomoni G; Pincelli C; Zambruno G; Andreani M; Giardini C; Lucarelli G; Giannetti A
    J Dermatol; 1991 Jun; 18(6):314-23. PubMed ID: 1939860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sequential study of histological and immunological changes in the skin after allogenic bone marrow transplantation.
    Guyotat D; Mauduit G; Chouvet B; Kanitakis J; Van HV; Fiere D; Thivolet J
    Transplantation; 1986 Mar; 41(3):340-2. PubMed ID: 3082048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LN-3: a diagnostic adjunct in cutaneous graft-versus-host disease.
    Synovec MS; Braddock SW; Jones J; Linder J
    Mod Pathol; 1990 Nov; 3(6):643-7. PubMed ID: 1702211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients.
    Sloane JP; Thomas JA; Imrie SF; Easton DF; Powles RL
    J Clin Pathol; 1984 Aug; 37(8):919-30. PubMed ID: 6381547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM; Katz SI
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MHC class I and II antigens by keratinocytes and enterocytes in acute graft-versus-host disease. Newcastle Bone Marrow Transplant Group.
    Sviland L; Pearson AD; Green MA; Eastham EJ; Malcolm AJ; Proctor SJ; Hamilton PJ
    Bone Marrow Transplant; 1989 May; 4(3):233-8. PubMed ID: 2659108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of the histological changes in the skin in patients receiving bone marrow transplants.
    Lever R; Turbitt M; Mackie R; Hann I; Gibson B; Burnett A; Willoughby M
    Br J Dermatol; 1986 Feb; 114(2):161-70. PubMed ID: 2936371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current understanding of the aetiology and clinical implications of cutaneous graft-versus-host disease.
    Breathnach SM
    Br J Dermatol; 1986 Feb; 114(2):139-43. PubMed ID: 3511941
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
    Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease.
    Volc-Platzer B; Majdic O; Knapp W; Wolff K; Hinterberger W; Lechner K; Stingl G
    J Exp Med; 1984 Jun; 159(6):1784-9. PubMed ID: 6202820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of HLA restricted anti-minor histocompatibility antigen(s) reactive cells from skin GVHD lesions.
    Reinsmoen NL; Kersey JH; Bach FH
    Hum Immunol; 1984 Dec; 11(4):249-57. PubMed ID: 6392220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of graft-versus-host reaction (GVHR)-type drug eruptions.
    Osawa J; Kitamura K; Saito S; Ikezawa Z; Nakajima H
    J Dermatol; 1994 Jan; 21(1):25-30. PubMed ID: 7908910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mononuclear cell subpopulations in the skin defined by monoclonal antibodies after HLA-identical sibling marrow transplantation.
    Atkinson K; Munro V; Vasak E; Biggs J
    Br J Dermatol; 1986 Feb; 114(2):145-60. PubMed ID: 3511942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
    Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
    J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathology of cutaneous graft-versus-host disease.
    Breathnach SM; Katz SI
    Am J Dermatopathol; 1987 Aug; 9(4):343-8. PubMed ID: 2443033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.